This NDC is on FDA's drug shortage list (posted Oct 12, 2022)

Reported reason: Shortage of an active ingredient

Product Information

DEXTROAMP-AMPHETAMINE 5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.2442 per EA under NDC 70010011101. Its NADAC has been published 157 times since Aug 9, 2023.

FDA first approved this application on Dec 28, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

70010011101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215771

FDA Approved

12/28/2021

TE Code

AB

On Market Since

3/28/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has been published 157 times since Aug 9, 2023, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2442 per EA
All-time high$0.3259 (Sep 13, 2023)
All-time low$0.1824 (Jul 17, 2024)
52-week high$0.2661
52-week low$0.2386
Median price$0.2553
Average price$0.2544
Largest weekly change+37.0% (Aug 21, 2024)
Weeks tracked157
Tracking sinceAug 9, 2023

Price History

1W

-2.1%

1M

-6.5%

3M

-7.5%

6M

-4.7%

1Y

+0.5%

3Y

-17.5%

5Y

N/A

All

-18.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMINE 5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMINE 5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.2442 per EA (NDC 70010011101), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHETAMINE 5 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has declined 18.5%. It has been tracked across 157 weekly CMS publications since Aug 9, 2023.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMINE 5 MG TAB?

Since Aug 9, 2023, the NADAC for DEXTROAMP-AMPHETAMINE 5 MG TAB has ranged from a low of $0.1824 (Jul 17, 2024) to a high of $0.3259 (Sep 13, 2023), with a median of $0.2553 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMINE 5 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMINE 5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMINE 5 MG TAB?

DEXTROAMP-AMPHETAMINE 5 MG TAB (NDC 70010011101) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.

Is DEXTROAMP-AMPHETAMINE 5 MG TAB in shortage?

Yes — NDC 70010011101 is currently listed in FDA's drug shortage database (posted Oct 12, 2022). Reported reason: Shortage of an active ingredient.